EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genome editing technology and applications with the type I CRISPR system

Kazuto Yoshimi, Tomoji Mashimo

Gene and Genome Editing · 2022-12 · 3-4 · 100013

DOI: 10.1016/j.ggedit.2022.100013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene and Genome Editing, 2022-12. Verfasst von Kazuto Yoshimi und 1 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems, which are representative genome editing technologies, are classified into class 1 and class 2 in terms of evolutionary biology and are further classified into several subtypes. Class 2 CRISPR systems, including type II Cas9 and type V Cas12a, are the most commonly used for genome editing in eukaryotic cells, while type I CRISPR systems within Class 1 are also becoming available. Type I CRISPR recognizes longer target sequences than CRISPR-Cas9 and can induce large deletion mutations of several kilobases. These features demonstrate its potential as a novel and unique genome editing tool that can induce genetic disruption safely and reliably. Thus, it is expected to be utilized for gene therapy and industrial applications. Recently, the DNA cleavage mechanism of type I CRISPR has also revealed details from protein-complex analyses with X-ray crystallography, cryo-electron microscopy, and high-speed atomic force microscopy. The single-strand DNA trans-cleavage activity of type I CRISPR, called collateral activity, has broadened the potential application for CRISPR diagnostics, especially in the development of point-of-care testing methods for COVID-19. In this review, we present an overview of the type I CRISPR system, its application to genome editing, and genetic diagnosis using CRISPR-Cas3.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yoshimi, K., & Mashimo, T. (2022). Genome editing technology and applications with the type I CRISPR system. Gene and Genome Editing, 3-4, 100013. https://doi.org/10.1016/j.ggedit.2022.100013

Vancouver

Yoshimi K, Mashimo T. Genome editing technology and applications with the type I CRISPR system. Gene and Genome Editing. 2022;3-4:100013. doi:10.1016/j.ggedit.2022.100013

BibTeX
@article{Yoshimi2022,
  author = {Yoshimi, Kazuto and Mashimo, Tomoji},
  title = {Genome editing technology and applications with the type I CRISPR system},
  journal = {Gene and Genome Editing},
  year = {2022},
  volume = {3-4},
  pages = {100013},
  doi = {10.1016/j.ggedit.2022.100013}
}
Kostenlos starten →